Prevention in Focus

Fall 2013 

Routine and Targeted Testing

What are the differences between routine and targeted testing strategies? Can these two testing approaches be seen as complementary?

By Len Tooley and Logan Broeckaert

Views from the Frontlines: Routine and Targeted Testing

We spoke to people from four organizations about HIV testing strategies.

Staying Safe: what people who inject drugs know about preventing Hep C and HIV

There are people who have been injecting drugs for a long time who have managed to “stay safe” from hepatitis C or HIV. The Staying Safe project looked at the strategies that people who use injection drugs have used to stay free of hepatitis C and HIV.

By Scott Anderson

Treatment and viral load: what do we know about their effect on HIV transmission?

How much can treatment reduce the risk of HIV transmission? What is the transmission risk when the viral load is undetectable? What do we know and don’t know about these questions and what are key messages for people living with HIV and their partners?

By James Wilton

Treatment as prevention: do the individual prevention benefits translate to the population level?

Treatment to prevent HIV transmission at the population level has led to the concept of a “seek, test and treat” strategy to maximize the prevention benefits of treatment. What do we know about the prevention benefits of this approach?

By James Wilton and Logan Broeckaert

Research Update: Male Call Canada

HIV disproportionately affects gay men and other MSM in Canada. Two recent surveys sought to understand the attitudes, opinions and behaviours of MSM – and their HIV prevention needs – to help inform and improve education, policies and programs.

New PHAC testing guide includes recommendations to promote HIV testing during routine medical care

PHAC’s HIV Screening and Testing Guide has recommendations to increase the uptake of HIV testing, reduce the proportion of people who are unaware of their HIV infection, and diagnose people as early as possible after HIV infection.

By James Wilton

PrEP works for people who use injection drugs

A recent trial has demonstrated that pre-exposure prophylaxis using daily tenofovir can reduce the risk of HIV transmission for people who use injection drugs.

By James Wilton

Finding prevention resources on the new CATIE website

We’ve recently redesigned our website. How can you quickly and easily find the prevention information and resources you need?

By Zak Knowles

The Programming Connection: Programs and resources

Read about selected Canadian programs that use novel approaches to improve access to HIV prevention, testing, treatment, care and support.

New prevention resources

A selection of prevention resources available from CATIE’s Ordering Centre.

Current research

Interested in checking out the latest Canadian research on HIV and hepatitis C prevention?


CATIE would like to thank the following people for their contribution to this issue of Prevention in Focus: Dan Allman, Scott Anderson, Michael Bailey, Logan Broeckaert, Melisa Dickie, Tsion Demeke Abate, Laurie Edmiston, Ken English, Thomas Haig, Brittany Howlett, Ed Jackson, Christie Johnston, Marc-André LeBlanc, Carol Major, Paul MacPherson, Frank McGee, Gina McKay, Ted Myers, Afshan Nathoo, Carla Pindera, Jim Pollock, Tim Rogers, Louise Slocombe, Len Tooley, Matt Watson, Erin Whiteway, James Wilton, Sara Young.

Editorial team: Laurel Challacombe, Logan Broeckaert, Zak Knowles.

The production of Prevention in Focus has been made possible through financial contributions from the Public Health Agency of Canada.